NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial
Go back to NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial| ANV Security Group, Inc. (NYSE: ANVS) | Delayed: 1.70 -0.04 (2.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.74 | 52 Week High | $0.04 | |||
| Open | $1.75 | 52 Week Low | $0.01 | |||
| Day High | $1.78 | P/E | N/A | |||
| Day Low | $1.69 | EPS | $-0.03 | |||
| Volume | 755,956 | |||||
